NCM
COCH icon

Nantahala Capital Management’s Envoy Medical COCH Stock Holding History

Nantahala Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Hold
7,650,000
– – 0.2% 102
2026
Q1 		$5.09M Buy
+7,650,000
New +$5.22M 0.19% 98

Other funds holding COCH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nantahala Capital Management's COCH Position: Q2 2026 in Review

Nantahala Capital Management held its Envoy Medical (COCH) position steady in Q2 2026 at 7,650,000 shares worth $5.96M. The position accounts for 0.2% of the portfolio, ranked #102.

Nantahala Capital Management first reported a position in COCH in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Nantahala Capital Management held 7,650,000 shares of Envoy Medical worth $5.96M as of Q2 2026.
  • Nantahala Capital Management left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up 0.2% of Nantahala Capital Management's portfolio in Q2 2026, its #102 holding.
  • Nantahala Capital Management first reported a position in Envoy Medical in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.